Real-world prevalence of prurigo nodularis and burden of associated diseases AH Huang, JK Canner, R Khanna, S Kang, SG Kwatra The Journal of investigative dermatology 140 (2), 480-483. e4, 2020 | 138 | 2020 |
Ethnic differences and comorbidities of 909 prurigo nodularis patients E Boozalis, O Tang, S Patel, YR Semenov, MP Pereira, S Stander, S Kang, ... Journal of the American Academy of Dermatology 79 (4), 714-719. e3, 2018 | 133 | 2018 |
Gabapentin and pregabalin for the treatment of chronic pruritus KM Matsuda, D Sharma, AR Schonfeld, SG Kwatra Journal of the American Academy of Dermatology 75 (3), 619-625. e6, 2016 | 116 | 2016 |
Prurigo nodularis: epidemiology and clinical features AH Huang, KA Williams, SG Kwatra Journal of the American Academy of Dermatology 83 (6), 1559-1565, 2020 | 115 | 2020 |
Dermatology practices as vectors for COVID-19 transmission: a call for immediate cessation of nonemergent dermatology visits SG Kwatra, RJ Sweren, AL Grossberg Journal of the American Academy of Dermatology 82 (5), e179-e180, 2020 | 106 | 2020 |
Prurigo nodularis: pathogenesis and management KA Williams, AH Huang, M Belzberg, SG Kwatra Journal of the American Academy of Dermatology 83 (6), 1567-1575, 2020 | 105 | 2020 |
Comparative efficacy of biologics in psoriasis: a review IH Kim, CE West, SG Kwatra, SR Feldman, JL O’Neill American journal of clinical dermatology 13, 365-374, 2012 | 104 | 2012 |
A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor‐mediated apoptosis in glioblastomas T Akazawa, SG Kwatra, LE Goldsmith, MD Richardson, EA Cox, ... Journal of neurochemistry 109 (4), 1079-1086, 2009 | 104 | 2009 |
Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus S Elmariah, B Kim, T Berger, S Chisolm, SG Kwatra, N Mollanazar, ... Journal of the American Academy of Dermatology 84 (3), 747-760, 2021 | 101 | 2021 |
Identification of a bilirubin receptor that may mediate a component of cholestatic itch J Meixiong, C Vasavda, D Green, Q Zheng, L Qi, SG Kwatra, JP Hamilton, ... Elife 8, e44116, 2019 | 98 | 2019 |
Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis KA Williams, YS Roh, I Brown, N Sutaria, P Bakhshi, J Choi, S Gabriel, ... Expert Review of Clinical Pharmacology 14 (1), 67-77, 2021 | 92 | 2021 |
A multidisciplinary toxicity team for cancer immunotherapy–related adverse events J Naidoo, J Zhang, EJ Lipson, PM Forde, K Suresh, KF Moseley, S Mehta, ... Journal of the National Comprehensive Cancer Network 17 (6), 712-720, 2019 | 84 | 2019 |
Cannabinoids for the treatment of chronic pruritus: A review C Avila, S Massick, BH Kaffenberger, SG Kwatra, M Bechtel Journal of the American Academy of Dermatology 82 (5), 1205-1212, 2020 | 79 | 2020 |
Association of cutaneous immune-related adverse events with increased survival in patients treated with anti–programmed cell death 1 and anti–programmed cell death ligand 1 therapy K Tang, J Seo, BC Tiu, TK Le, V Pahalyants, NS Raval, PO Ugwu-Dike, ... JAMA dermatology 158 (2), 189-193, 2022 | 74 | 2022 |
Breaking the itch–scratch cycle in prurigo nodularis SG Kwatra New England Journal of Medicine 382 (8), 757-758, 2020 | 71 | 2020 |
Female-specific pruritus from childhood to postmenopause: clinical features, hormonal factors, and treatment considerations LP Rimoin, G Yosipovitch, M McKay Skin, Mucosa and Menopause: Management of Clinical Issues, 111-124, 2014 | 70 | 2014 |
Prurigo nodularis is characterized by systemic and cutaneous T helper 22 immune polarization M Belzberg, MP Alphonse, I Brown, KA Williams, R Khanna, B Ho, ... Journal of Investigative Dermatology 141 (9), 2208-2218. e14, 2021 | 68 | 2021 |
Quality of life in family members of vitiligo patients: a questionnaire study in Saudi Arabia GA Bin Saif, AO Al-Balbeesi, R Binshabaib, D Alsaad, SG Kwatra, ... American journal of clinical dermatology 14, 489-495, 2013 | 67 | 2013 |
Aprepitant for the treatment of chronic refractory pruritus A He, JM Alhariri, RJ Sweren, MM Kwatra, SG Kwatra BioMed research international 2017, 2017 | 63 | 2017 |
Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis S Wongvibulsin, V Pahalyants, M Kalinich, W Murphy, KH Yu, F Wang, ... Journal of the American Academy of Dermatology 86 (3), 563-572, 2022 | 61 | 2022 |